Carboxylesterase Notum Is a Druggable Target to Modulate Wnt Signaling

Elliott D Bayle1,2, Fredrik Svensson1,2, Benjamin N Atkinson1

  • 1Alzheimer's Research UK UCL Drug Discovery Institute, University College London, Cruciform Building, Gower Street, London WC1E 6BT, U.K.

Insights

Inhibiting Notum carboxylesterase activity offers a novel therapeutic strategy for diseases linked to Wnt signaling pathway dysregulation. Small molecule inhibitors are being developed to target Notum, providing new tools for research and treatment.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Pharmacology

Background:

  • The Wnt signaling pathway is crucial for mammalian development and adult biology.
  • Aberrant Wnt signaling is implicated in various diseases.
  • Notum carboxylesterase negatively regulates Wnt signaling by removing a palmitoleate group.

Purpose of the Study:

  • To summarize therapeutic opportunities in modulating Wnt signaling.
  • To highlight the potential of inhibiting Notum carboxylesterase activity.
  • To present small molecule inhibitors of Notum as research tools.

Main Methods:

  • Review of current literature on Wnt signaling and Notum.
  • Discussion of screening technologies for Notum inhibitors.
  • Optimization of identified hits into small molecule inhibitors.

Main Results:

  • Notum's role as a negative regulator of Wnt signaling is established.
  • Screening and structural studies have accelerated the discovery of Notum inhibitors.
  • Several potent small molecule inhibitors, including LP-922056, ABC99, and ARUK3001185, have been developed.

Conclusions:

  • Inhibition of Notum activity presents a promising therapeutic avenue for diseases associated with its aberrant function.
  • Developed small molecule inhibitors serve as valuable chemical tools for further investigation of Notum's role in Wnt signaling.
  • Targeting Notum offers a new strategy for treating diseases driven by Wnt pathway dysregulation.

Related Concept Videos

Canonical Wnt Signaling Pathway02:54

Canonical Wnt Signaling Pathway

The gene encoding the main signaling molecules of the Wnt signaling pathways (the Wnt proteins) was discovered almost four decades ago by Nüsslein-Volhard and Wieschaus. They identified and originally named the gene "wingless" (wg) after a phenotype discovered during their landmark genetic screen in Drosophila for body pattern defects. At around the same time, another researcher named Harold Varmus found that a murine tumor virus activates the mammalian wg homolog, Int-1, which...
9.5K
Non-Canonical Wnt Signaling Pathways01:41

Non-Canonical Wnt Signaling Pathways

Wnt is a zygotic effect gene that is expressed during very early embryonic development. It regulates various processes in animals starting from early development through the adult stage, such as organogenesis in the embryo and maintenance of neuronal and blood stem cells. Wnt proteins can induce a wide variety of intracellular pathways depending upon the specific abilities of different Wnt ligands to form a complex with shared and cognate receptors in the presence of different co-receptors. The...
7.8K
Transducer Mechanism: Enzyme-Linked Receptors01:27

Transducer Mechanism: Enzyme-Linked Receptors

Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
3.4K
Notch Signaling Pathway03:14

Notch Signaling Pathway

The Notch signaling pathway is a major intracellular signaling pathway that is highly conserved over a broad spectrum of metazoan species. It stands unique from other intracellular signaling mechanisms in animals because notch protein itself acts as the receptor as well as the primary signaling molecule.
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not...
4.7K
Role Of Notch Signalling In Intestinal Stem Cell Renewal01:12

Role Of Notch Signalling In Intestinal Stem Cell Renewal

Notch signaling was first discovered in Drosophila melanogaster, where it is involved in cell lineage differentiation. Notch signaling regulates the maintenance and differentiation of intestinal stem cells or ISCs by controlling the expression of atonal homolog 1 or Atoh1. Atoh1 directs cells to differentiate into secretory cells.
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
2.2K
Targets for Drug Action: Overview01:26

Targets for Drug Action: Overview

Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
8.8K